PHARMACIE PIERRES VIVES : revenue, balance sheet and financial ratios

PHARMACIE PIERRES VIVES is a French company founded 10 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MONTPELLIER (34080), this company of category PME shows in 2017 a revenue of 698 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE PIERRES VIVES (SIREN 813620564)
Indicator 2022 2021 2020 2017 2016
Revenue N/C N/C N/C 698 066 € 869 123 €
Net income 141 019 € 187 605 € 44 091 € 32 638 € -7 171 €
EBITDA N/C N/C N/C 34 325 € 5 271 €
Net margin N/C N/C N/C 4.7% -0.8%

Revenue and income statement

In 2022, PHARMACIE PIERRES VIVES generates positive net income of 141 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2022) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

141 019 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 107%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 43%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2022) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

106.929%

Financial autonomy (2022) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

42.959%

Asset age ratio (2022) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

50.0%

Solvency indicators evolution
PHARMACIE PIERRES VIVES

Sector positioning

Debt ratio
106.93 2022
2020
2021
2022
Q1: 24.52
Med: 74.72
Q3: 182.51
Average -18 pts over 3 years

In 2022, the debt ratio of PHARMACIE PIERRES VIVES (106.93) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
42.96% 2022
2020
2021
2022
Q1: 28.54%
Med: 47.06%
Q3: 66.61%
Average +20 pts over 3 years

In 2022, the financial autonomy of PHARMACIE PIERRES VIVES (43.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 204.60. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2022) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

204.604

Liquidity indicators evolution
PHARMACIE PIERRES VIVES

Sector positioning

Liquidity ratio
204.6 2022
2020
2021
2022
Q1: 145.17
Med: 199.48
Q3: 274.99
Good -23 pts over 3 years

In 2022, the liquidity ratio of PHARMACIE PIERRES VIVES (204.60) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2022) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2022) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2022) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2022) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE PIERRES VIVES

Positioning of PHARMACIE PIERRES VIVES in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 215 transactions of similar company sales in 2022, the value of PHARMACIE PIERRES VIVES is estimated at 1 659 301 € (range 1 115 380€ - 2 488 643€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2022
215 transactions
1115k€ 1659k€ 2488k€
1 659 301 € Range: 1 115 380€ - 2 488 643€
NAF 5 année 2022

Valuation method used

Net Income Multiple
141 019 € × 11.8x = 1 659 301 €
Range: 1 115 380€ - 2 488 644€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE PIERRES VIVES with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE PIERRES VIVES

What is the revenue of PHARMACIE PIERRES VIVES ?

The revenue of PHARMACIE PIERRES VIVES in 2017 is 698 k€.

Is PHARMACIE PIERRES VIVES profitable?

Yes, PHARMACIE PIERRES VIVES generated a net profit of 141 k€ in 2022.

Where is the headquarters of PHARMACIE PIERRES VIVES ?

The headquarters of PHARMACIE PIERRES VIVES is located in MONTPELLIER (34080), in the department Herault.

Where to find the tax return of PHARMACIE PIERRES VIVES ?

The tax return of PHARMACIE PIERRES VIVES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE PIERRES VIVES operate?

PHARMACIE PIERRES VIVES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.